My watch list
my.bionity.com  
Login  

Vaccines

Companies Vaccines

SIRION BIOTECH GmbH, Germany

SIRION Biotech is Europe's leading commercial supplier of viral vectors used for genetic cell modelling, gene target validation and gene therapy- and vaccination studies. Since its foundation in 2007, SIRION’s mission has been to change the paradigm for viral vector supplies. It has the ability to more

Products Vaccines

Next Gen Viral Vectors for Gene Therapy & Novel Vaccines

Viral vectors are one of the top 3 topics in drug development. The discussions center on improved transductions and safety, specifically tissue specificity, titers and purity. SIRION Biotech is in Europe the #1 reference when it comes to sourcing viral vectors due to its experience with more than 500 single projects for more than 150 clients more

News Vaccines

  • Reminding people about vaccinations can increase rates of immunization

    Rates of immunization against infectious diseases in children and adults are improving, but under-vaccination remains a problem that results in vaccine-preventable deaths and illnesses. In Europe, 11,316 cases of measles were reported during 2012, and an estimated four to 50 million symptomatic case more

  • Zika vaccine induces strong immune response in three phase 1 studies

    Three Phase 1 human clinical trials evaluating an Army-developed Zika purified inactivated virus (ZPIV) vaccine have shown it was safe and well-tolerated in healthy adults and induced a robust immune response. Each of the three studies included in the paper was designed to address a unique question more

  • New vaccine technique effectively fights breast cancer in mice

    A new vaccine technique can fight a certain type of breast cancer in mice. So-called HER2-positive breast cancer accounts for between 20 and 30 per cent of all cases of breast cancer in humans. Researchers from the University of Copenhagen and the University of Bologna now show that the same type of more

All news on vaccines

Infographics Vaccines

A Summary of Common Vaccine Components

The recent measles outbreak in the US has once again provoked discussion over vaccinations, and why some parents choose not to vaccinate their children despite the benefits of doing so. Whilst not the only factor, part of the blame lies with misinformation about the chemical composition of vaccines more

Events Vaccines

Conference
01-06 – 04-06
2018
Nassau, BS

Targeting Therapy of Alzheimer’s and Related Neurodegenerative Diseases

Alzheimer’s disease (AD) is the most common age-dependent neurodegenerative disease, which affects over 5 million people in the US and over 35 million people worldwide. Currently, only four drugs are approved for alleviating symptoms in AD patients, and no new therapy has been approved for AD since

Conference
10-06 – 15-06
2018
Newport, US

Biology of Host-Parasite Interactions

The 2018 GRC on the Biology of Host-Parasite Interactions is focused on new molecular and translational advances in parasitic diseases. The conference will emphasize the fundamental biology of a wide range of human and veterinarian pathogens that cause malaria, toxoplasmosis, trypanosomiasis, leishm

Conference
10-06 – 15-06
2018
West Dover, US

Immunochemistry and Immunobiology

The field of immunology witnesses a period of extraordinary and unprecedented discovery and advancement in virtually every aspect of basic and clinical research. These progresses are in part the result of technological advances which enable us to quantitatively and comprehensively measure the immune

Publications Vaccines

All publications on vaccines

Market studies Vaccines

  • Vaccines - Senegal

    This market research report offers an in-depth perspective on the actual market situation, trends and future outlook for vaccines in Senegal. The analysis provides essential market information for decision-makers including:   * Overall market value for vaccines in Senegal * Overall market volume for more

  • iBio, Inc. (NYSE ) - Financial and Strategic SWOT Analysis Review

    iBio, Inc. (iBio, formerly iBioPharma, Inc.) is a biotechnology company, engaged in the development of vaccines and therapeutic proteins based on its plant-based iBioLaunch platform technology, which is used in the manufacture of biopharmaceuticals. Its products include influenza vaccines, biodefenc more

  • Iran Pharmaceuticals and Healthcare Report Q2 2012

    BMI View: We continue viewing Iran as one of the less attractive regional markets. Imposition of more stringent international sanctions, rampant inflation, and the loss of confidence in the Iranian rial weigh heavily on consumption and investment patterns, and also on government revenues and the aut more

All market studies on vaccines
Definition

Timeline of vaccines

Timeline of vaccines This is a timeline of the development of prophylactic human vaccine s. Early vaccines may be listed by the first year of development or testing, but later entries usually show the year the vaccine finished trials and became ... more

Watchlist

This is where you can add this topic to your personal favourites

Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE